Asia-focused PE firm PAG, along with consortium partners CX Partners and Samara Capital, have acquired a controlling stake in Chennai-based manufacturer of active pharmaceutical ingredients Anjan Drug for about $70-80 million.
The acquisition is part of PAG-led consortium’s strategy to create a platform for development and production of bulk drug ingredients.
Anjan, founded by C Kalaichelvan in 1990, is a supplier of active drug ingredients in the central nervous system therapy segment to markets including the US, Canada, Brazil and Europe.
Following the deal, the PAG-led consortium will set up a platform to tap into the consolidation opportunities in India’s high-growth API manufacturing industry.
‘Attractive opportunity’
“We see the Indian API market as a very attractive opportunity and well positioned for the future. Globally, this sector is currently growing at an estimated 8 per cent a year, with India, one of the three largest API producers in the world, growing even faster than that. By building a platform incorporating exceptional API producers like Anjan, we plan to develop a high quality, diversified portfolio of products with a solid client base and a broad range of technical expertise,” said Nikhil Srivastava, Managing Director and head of India private equity at PAG.
India plans
PAG is currently investing out of its $6-billion PAG Asia III buyout fund and has declared plans to invest up to $1 billion in India over the next few years.
CX Partners is an Indian private equity fund, while Samara Capital is a mid-market private equity firm investing in emerging Indian companies.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.